About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 ...

With deaths from obesity-related heart disease reportedly increasing by 180% over the past 20 years, more research is being done to learn how GLP-1 medications such as Ozempic, Wegovy, Mounjaro and ...

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Using the Saxenda pen correctly is essential for safe and effective weight loss management. While the pen is designed to be user-friendly, many people make mistakes that can reduce its effectiveness ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

More than 7 million Americans struggling with obesity would become eligible for coverage under the proposed change ...

Rybelsus in combination with standard T2DM therapy reduced the risk of major cardiovascular events by 14% in patients with ...

Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...

Skeletal Muscle Health Amid Growing Use of Weight Loss Medication. A recent commentary published in The Lancet journal highlights the critical importance of skeletal ...

While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.